EDITORIAL / 08
About Get CJC-1295: a stencilled spec sheet of the research record.
An independent editorial project that reads the published CJC-1295 literature and cites it. No clinic, no counter, nothing dispensed.
What this site is
Get CJC-1295 is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site is built as a research console: a stencilled spec sheet of what the pharmacokinetic and preclinical literature actually measured. Each figure — the 5.8-8.1-day DAC half-life [1], the roughly 45% IGF-1 rise a week after a single dose [2], the once-daily mouse-growth normalization [4] — is tagged to the study it comes from, and the full reference list collects them all in one place.
What 'Get' means here, and what it does not
The word 'get' in the domain name is editorial framing: get the facts on CJC-1295, in one place, cited. It is not an offer to sell, source, or supply the compound. This site does not list prices, vendors, or order links, and it never will within this project — the negative terms it deliberately avoids (buy, for sale, sources, vendor, order) are not part of an editorial digest.
Likewise, the site occupies a position relative to the literature, not a healthcare role. There is no doctor, pharmacist, or clinical team behind these pages — only an editorial reading of published research. CJC-1295 is not approved for human use anywhere, and everything here is framed as research context, never as treatment, consultation, or a prescription [12].
How the record is handled
We prioritize primary sources: peer-reviewed journals, PubMed-indexed studies, and the original pharmacokinetic and preclinical reports [1][2][3][4]. Where a claim is a mechanism extrapolation rather than a measured outcome — as with the sleep and recovery material — the page says so [12][14]. Where the evidence is preclinical rather than human, it is labeled. Where the registry sources disagree, as they do on the exact molecular formula, the discrepancy is noted rather than smoothed over.
The aim is a precise instrument of record: what was measured, in which species, at which dose, with the honest gaps left visible. A figure that comes from a rat study is presented as a rat study; a half-life that belongs to the DAC form is not borrowed by the no-DAC form. That discipline is the whole point of the site.
What the editorial framing is, and is not
The domain modifier — 'get' — is the kind of word a storefront would use, and this site is deliberately the opposite of a storefront. It exists to make the published CJC-1295 record legible in one place: the human pharmacokinetic studies that fixed the GH and IGF-1 numbers [1][2], the rat and knockout-mouse work behind the long-acting design [3][4], and the regulatory and safety context that any reader weighing the compound should see first [12].
We do not make medical claims, we do not recommend or imply a course of use, and we do not endorse CJC-1295. We summarize what researchers have reported and we cite it. Readers who want to verify a figure can follow the citation to its source; the references page lists every one with a PubMed ID or DOI. An editorial digest earns trust by being checkable, and being checkable is the standard this project holds itself to.
Nothing here substitutes for a qualified healthcare professional. CJC-1295 is an unapproved research chemical, and any decision involving it sits with a clinician and the law, not with a reading room. This site is the reading room.